Cargando…

COVID-19: molecular diagnostics overview

The last day of 2019 delivered the first report to the World Health Organization (WHO) about a group of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified the new comer, a novel coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV)...

Descripción completa

Detalles Bibliográficos
Autor principal: Touma, Marlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293435/
https://www.ncbi.nlm.nih.gov/pubmed/32535768
http://dx.doi.org/10.1007/s00109-020-01931-w
_version_ 1783546303702106112
author Touma, Marlin
author_facet Touma, Marlin
author_sort Touma, Marlin
collection PubMed
description The last day of 2019 delivered the first report to the World Health Organization (WHO) about a group of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified the new comer, a novel coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV) and thus was termed as SARS-CoV-2. Being very contagious, the new virus led the era of “COVID-19” which is the acronym of “coronavirus disease 2019,” evoking an imminent threat to global health security with unprecedented devastating challenges to human kind. In this article, we provide a molecular overview on the SARS-CoV-2 virus and summarize tremendous efforts that have been made to develop a rapid confirmatory diagnostic test for COVID-19. The diagnostic performances of the available tests are analyzed based on the best current information from the early research.
format Online
Article
Text
id pubmed-7293435
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-72934352020-06-14 COVID-19: molecular diagnostics overview Touma, Marlin J Mol Med (Berl) Review The last day of 2019 delivered the first report to the World Health Organization (WHO) about a group of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified the new comer, a novel coronavirus related to severe acute respiratory syndrome coronavirus (SARS-CoV) and thus was termed as SARS-CoV-2. Being very contagious, the new virus led the era of “COVID-19” which is the acronym of “coronavirus disease 2019,” evoking an imminent threat to global health security with unprecedented devastating challenges to human kind. In this article, we provide a molecular overview on the SARS-CoV-2 virus and summarize tremendous efforts that have been made to develop a rapid confirmatory diagnostic test for COVID-19. The diagnostic performances of the available tests are analyzed based on the best current information from the early research. Springer Berlin Heidelberg 2020-06-13 2020 /pmc/articles/PMC7293435/ /pubmed/32535768 http://dx.doi.org/10.1007/s00109-020-01931-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Touma, Marlin
COVID-19: molecular diagnostics overview
title COVID-19: molecular diagnostics overview
title_full COVID-19: molecular diagnostics overview
title_fullStr COVID-19: molecular diagnostics overview
title_full_unstemmed COVID-19: molecular diagnostics overview
title_short COVID-19: molecular diagnostics overview
title_sort covid-19: molecular diagnostics overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293435/
https://www.ncbi.nlm.nih.gov/pubmed/32535768
http://dx.doi.org/10.1007/s00109-020-01931-w
work_keys_str_mv AT toumamarlin covid19moleculardiagnosticsoverview